SARS-COV-2 is the etiologic agent of COVID-19. There is currently no effective means of preventing infections by SARS-COV-2, except through restriction of population movement and contact. An understanding of the origin, evolution and biochemistry (molecular biology) of SARS-COV-2 is a prerequite to its control. There is no definitive answer as to the origin of SARS-COV-2. The evolution of SARS-COV-2 can be gleaned from a comparative study of its infectivity and virulence in different populations and environments. From an analysis of the infectivity and virulence of SARS-COV-2 in different parts of the world, it is submitted that there is no correlation between infectivity and virulence of SARS-COV-2. It is therefore hypothesized that SARS-COV-2 may be a rapidly mutating virus and identification of SARS-COV-2 strain(s) that has/have increased virulence is essential in the formulation of any effective vaccine or prophylactic that targets SARS-COV-2.
Author and article information
] Nachbraht Biomedical Research Institute
This work has been published open access under Creative Commons Attribution License
CC BY 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided
can be found at
Data availability: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.